21 May 2009
Graft versus host disease – a rare complication after liver transplantation
M Markiewicz-Kijewska, J Teisseyre, P Kaliciński, P Kluge, M TeisseyreAnn Transplant 2009; 14(1): 42-42 :: ID: 880352
Abstract
Background: Graft versus host disease after liver transplantation develops extremely rare, but always is a life threatening complication. In the literature we found about 85 cases reported until now that included 10 children. We report additional case of GvHD in a paediatric liver transplant recipient.
Case Report: 16 months old boy received living related donor (father) liver
transplantation after failed hapatoportoenterostomy due to congenital biliary atresia. Both, donor and recipient were of identical blood group and pre-transplant cross-match was negative. Primary immunosuppression consisted of tacrolimus and mycophenolate mofetil. Early post-transplant course was excellent, but after 7 weeks he developed mild upper respiratory distress which was treated with oral cephalosporin. Three days later he developed a skin rash followed by little blisters and ulcerative changes. There were no laboratory abnormalities but relative leucopenia, with increased number of eosinophils and CRP. Skin biopsy confirmed suspicion of graft versus host disease of grade II/III. Local therapy was introduced with colloid dressings and tacrolimus was discontinued, while corticosteroid boluses (5-10 mg/kg body mass) and daclizumab (1 mg/kg body mass) were started. Despite that, further deterioration was observed and we decided to treat the child with ATG, however the child died of MOF after next 9 days despite all possible intensive therapy.
Conclusions: GvHD is very serious complication with high mortality rate. There is no standard for the effective therapy of problem.
Keywords: Liver Transplantation, case report
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860